Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do supervised injecting facilities attract higher-risk injection drug users?

Evan Wood1, Mark W Tyndall, Kathy Li

  • 1British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada. ewood@cfenet.ubc.ca

American Journal of Preventive Medicine
|July 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased Severity of Multidrug-Resistant Shigella sonnei Infections in People Experiencing Homelessness.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2024
Same author

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2020
Same author

Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2020
Same author

Patterns of social determinants of health associated with drug use among women living with HIV in Canada: a latent class analysis.

Addiction (Abingdon, England)·2019
Same author

Challenging the assertion of comparability of surveillance and administrative data.

Infection control and hospital epidemiology·2018
Same author

Clinical heterogeneity of patients with stool samples testing PCR+/Tox- from a two-step Clostridium difficile diagnostic algorithm.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2018

Safer injection facilities (SIFs) successfully attract high-risk injection drug users (IDUs), including those younger than 30, experiencing homelessness, and using drugs daily. These facilities help reduce public drug use and unsafe syringe disposal.

Area of Science:

  • Public Health
  • Addiction Medicine
  • Epidemiology

Background:

  • Medically supervised safer injection facilities (SIFs) are increasingly implemented globally to mitigate harms associated with injection drug use (IDU).
  • Limited evaluations exist, raising questions about SIFs' effectiveness in reaching high-risk populations.
  • This study addresses the need to evaluate if North America's first SIF attracted injection drug users (IDUs) most vulnerable to overdose and blood-borne infections.

Purpose of the Study:

  • To determine if North America's first safer injection facility (SIF) attracted injection drug users (IDUs) at the highest risk for overdose and blood-borne disease infection.
  • To identify predictors of SIF initiation among IDUs based on pre-opening behavioral data.

Main Methods:

  • A community-recruited cohort study of injection drug users (IDUs) was conducted.

Related Experiment Videos

  • Questionnaire data collected before and after the SIF's opening assessed SIF use prevalence and predictors.
  • Pearson's chi-square test was employed to compare characteristics of IDU groups.

    • Main Results:

    • Out of 400 active injection drug users (IDUs) followed, 45% reported using the SIF.
    • IDUs initiating SIF use were significantly more likely to be younger than 30, engage in public drug use, experience homelessness, use heroin or cocaine daily, and have had a recent nonfatal overdose.

    Conclusions:

    • The safer injection facility (SIF) successfully attracted injection drug users (IDUs) identified as high-risk for blood-borne infections and overdose.
    • The SIF also engaged IDUs contributing to public drug use and unsafe syringe disposal issues.